Loading
Invacare Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by TENOR CAPITAL MANAGEMENT Co., L.P., was filed 30 Oct 2024.
Invacare Corp: what insiders have been doing
Invacare Corp, classified in the Healthcare & Pharma sector, is a listed company based in Elyria, Germany, founded in 1979. Its insiders report their share dealings to SEC (Form 4). Invacare Corp has had no insider filing for more than a year; the last one goes back to 31 October 2024.
Our records for Invacare Corp go back to 2016, with 26 purchases and 20 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
241
Thresholds
n/a
Buy Volume
€1M
26 ops. · all time
Sell Volume
€992,199
20 ops. · all time
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$638.6M
Gross profitUS$151M24% margin
Net income-US$87M-13.6% margin
Last declaration on 31 October 2024
Declarations241 total
472,865 sharesSeries B Redeemable Preferred Stock(non-convertible)SEC:0000902664-24-006102:0
912,980 sharesSeries B Redeemable Preferred Stock (non-convertible)SEC:0000950170-24-119157:0
Canonical exit: 27 Jan 2025 (T+90)
2,431,075 sharesSeries B Redeemable Preferred Stock (non-convertible)SEC:0000950170-24-119161:0
Canonical exit: 27 Jan 2025 (T+90)
713,698 sharesSeries B Redeemable Preferred Stock (non-convertible)SEC:0000950170-24-119148:0
Canonical exit: 27 Jan 2025 (T+90)
1,408,002 sharesSeries B Redeemable Preferred Stock (non-convertible)SEC:0000950170-24-119158:0
Canonical exit: 27 Jan 2025 (T+90)
4,182,724 shares0Common StockSEC:0000950170-24-032410:0
2,705,409 shares0Common StockSEC:0000950170-24-032426:0
2,114,876 shares0Common StockSEC:0000950170-24-032412:0
1,404,736 sharesCommon Stock, par value $0.001 per share ("Common Stock")SEC:0000902664-24-002472:0
252,000 shares0Common StockSEC:0001209191-23-054378:0
66,860 shares0Common StockSEC:0001209191-23-054356:0
66,860 shares0Common StockSEC:0001209191-23-054372:0
140,000 shares0Common StockSEC:0001209191-23-054381:0
66,860 shares0Common StockSEC:0001209191-23-054367:0
66,860 shares0Common StockSEC:0001209191-23-054360:0
84,000 shares0Common StockSEC:0001209191-23-054386:0
66,860 shares0Common StockSEC:0001209191-23-054365:0
1,204,000 shares0Common StockSEC:0001209191-23-054383:0
87,209 shares0Common StockSEC:0000950170-23-058873:0
535,312 sharesCommon SharesSEC:0000899243-23-013758:1
3,665,233 shares0Common SharesSEC:0000899243-23-013758:0
4,976 shares0Common SharesSEC:0001209191-23-027817:1
3,665,233 shares0Common SharesSEC:0000899243-23-012359:0
86,118 shares0Common SharesSEC:0001209191-23-027809:0
3,665,233 shares0Common SharesSEC:0000899243-23-012358:0
25 of 241 declarations
About Invacare Corp
Invacare Corp. (NYSE: IVC) is a U.S.-listed medical equipment company traded on the NYSE in the United States. The company is headquartered in Elyria, Ohio, and its business is focused on non-acute care, home care, and rehabilitation-oriented medical devices. Its core proposition is to design, manufacture, and distribute products that support mobility, positioning, daily living, and independence for patients in home, long-term care, and rehabilitation settings. ([invacare.com](https://www.invacare.com/?utm_source=openai))
Invacare’s origins go back to December 1979, when it became a stand-alone enterprise. Early on, the company had a relatively limited product set centered on standard wheelchairs and patient aids, but over time it built a broader portfolio and distribution footprint. That history matters for investors because it helps explain the company’s long-standing brand recognition in assistive and home-medical products. ([sec.gov](https://www.sec.gov/Archives/edgar/data/742112/000074211217000019/a2016ivc10-k.htm?utm_source=openai))
Read moreShow less
Today, the company’s main business lines are concentrated in mobility and seating, complemented by lifestyle and daily-living solutions. Its portfolio includes manual wheelchairs, powered wheelchairs, seating and positioning systems, patient transfer and bathing equipment, therapeutic beds and mattresses, patient lifts and slings, and personal care aids. In recent company communications, Invacare has described a strategic reset toward its core lifestyle and mobility & seating categories, while exiting or de-emphasizing non-core activities. ([global.invacare.com](https://global.invacare.com/news/invacare-holdings-corporation-and-miga-holdings-llc-announce-migas-acquisition-of-invacares-north-american-business/?utm_source=openai))
From a competitive standpoint, Invacare operates in a specialized segment of the healthcare equipment market rather than in mass-market consumer healthcare. Its differentiation comes from clinical relevance, breadth of offering, and channel relationships with home medical equipment providers, retail and e-commerce partners, residential care operators, distributors, and government health services. The company’s competitive set includes both regional specialists and larger medical-device suppliers, making execution, product innovation, and reimbursement dynamics particularly important. ([sec.gov](https://www.sec.gov/Archives/edgar/data/742112/000095015207001879/l24944be10vkza.htm?utm_source=openai))
Geographically, Invacare has historically served North America, Europe, and Asia-Pacific through an international distribution network. Recent disclosures indicate a further realignment of the EMEA and APAC businesses and a broader simplification of the operating structure, suggesting management is prioritizing capital efficiency and operational focus over global breadth for its own sake. ([newsroom.invacare.com](https://newsroom.invacare.com/news/invacare-corporation-announces-strategic-realignment-of-emea-apac-businesses/?utm_source=openai))
Recent milestones are centered on restructuring and portfolio rationalization. Invacare emerged from Chapter 11 in May 2023 and has since framed its strategy around operational excellence and profitable long-term growth in core product categories. For equity investors, that means the stock remains a transformation story: a legacy U.S. NYSE-listed healthcare equipment supplier with a recognized brand, but also with exposure to reimbursement pressure, supply-chain execution, and the pace at which the turnaround translates into sustainable growth. ([newsroom.invacare.com](https://newsroom.invacare.com/news/invacare-holdings-corporation-completes-financial-restructuring-and-is-well-positioned-to-drive-forward-in-its-transformation/?utm_source=openai))
